Clinical Trial: A Study to Evaluate the Safety and Efficacy of ALKS 7290 as an Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder

U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07901179) titled 'A Study to Evaluate the Safety and Efficacy of ALKS 7290 as an Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder' on Oct. 22.

Brief Summary: The purpose of this study is to assess the efficacy, safety and tolerability of ALKS 7290 following oral administration in adult participants with Major Depressive Disorder.

Study Start Date: Oct., 2026

Study Type: INTERVENTIONAL

Condition: Major Depressive Disorder (MDD)

Intervention: DRUG: ALKS 7290 Dose

Daily oral ALKS 7290 with antidepressant therapy

DRUG: Placebo

Daily oral placebo with antidepressant therapy

Recruitment Status: RECRUITING...